Oncology Clinical Trials in Nashville, TN

As of September 2026, 401 paid clinical trials are recruiting for Oncology in Nashville, Tennessee. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Nashville

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

for Prostate Cancer

Drug: JANX007

1 location in Nashville

Sponsor: Janux Therapeutics

Sex: Male·Age: 18+

Code: NCT07813637·Phase 1·Recruiting·Listed Sep 10, 2026

Apply to this trial

402 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Nashville, TN.

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for Solid Tumors

Drug: INCB161734

Sites in Nashville +68 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07522073·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

Drug: PF-08634404

Sites in Nashville, Hendersonville +131 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for Non-small Cell Lung Cancer (NSCLC)

Drug: Durvalumab

Sites in Nashville +36 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07361497·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for Carcinoma, Renal Cell

Drug: PF-08634404

Sites in Nashville, Hendersonville +138 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

Drug: PF-08634404

Sites in Nashville, Mount Juliet +204 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

Drug: PF-08634404

Sites in Nashville +199 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

for Breast Neoplasms

Sites in Nashville +31 more locations

Sponsor: Eli Lilly and Company

Sex: Female·Age: 18+

Code: NCT07287098·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Cancer

Drug: daraxonrasib

Sites in Nashville +42 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Nashville +7 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07266441·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for Breast Neoplasms

Sites in Nashville +125 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in Nashville +44 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

Sites in Nashville, Memphis +170 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

for Breast Neoplasms

Sites in Nashville, Germantown +47 more locations

Sponsor: Natera, Inc.

Sex: All·Age: 18+

Code: NCT07214532·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for Carcinoma, Non-Small-Cell Lung

Drug: Amivantamab

Sites in Nashville, Chattanooga +123 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

Sites in Nashville, Chattanooga +89 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Nashville +38 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Drug: Mevrometostat

Sites in Nashville, Hendersonville +122 more locations

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for Breast Neoplasms

Sites in Nashville, Knoxville +61 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06966700·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

Drug: LY3537982

Sites in Nashville, Chattanooga +89 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for Breast Neoplasms

Drug: Pumitamig

Sites in Nashville, Germantown +69 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07173751·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

Drug: LY3537982

Sites in Nashville, Chattanooga +86 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for Neoplasms

Sites in Nashville +76 more locations

Sponsor: Celgene

Sex: All·Age: All ages

Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018

Apply to this trial

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for Colorectal Neoplasms

Drug: Amivantamab

Sites in Nashville, Chattanooga +66 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for Non-Small Cell Lung Cancer

Drug: Telisotuzumab Vedotin

Sites in Nashville +38 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06568939·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

Sites in Nashville +40 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for Colorectal Neoplasms

Drug: Amivantamab

Sites in Nashville +80 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06662786·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

Sites in Nashville +43 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for Chronic Lymphocytic Leukemia

Drug: Nemtabrutinib

Sites in Nashville, Chattanooga +41 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06136559·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for Carcinoma, Non-Small-Cell Lung

Drug: Adagrasib

Sites in Nashville +48 more locations

Sponsor: Mirati Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06875310·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for HER2-positive Breast Cancer

Sites in Nashville +28 more locations

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07102381·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for Breast Cancer

Sites in Nashville, Germantown +59 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for Breast Neoplasms

Sites in Nashville +33 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07060807·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for Chronic Lymphocytic Leukemia

Sites in Nashville +46 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06973187·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

Sites in Nashville +60 more locations

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

for Metastatic Colorectal Cancer

Sites in Nashville +19 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT04929223·Phase 1·Recruiting·Listed Jun 2021

Apply to this trial

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for Metastatic Breast Cancer

Drug: Zongertinib

Sites in Nashville, Memphis +24 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06324357·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for PIK3CA Mutation

Sites in Nashville, Knoxville +50 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06982521·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

Sites in Nashville +107 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for Carcinoma, Non-Small-Cell Lung

Drug: Intismeran autogene

Sites in Nashville, Chattanooga +48 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for Mantle Cell Lymphoma

Drug: Sonrotoclax

Sites in Nashville +40 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06742996·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

Top Research Study Locations in Nashville

Researchers run research studies in Nashville, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
Vanderbilt University Medical Center	Colorectal Cancer, Critical Illness, Parkinson Disease	374
SCRI Oncology Partners	Breast Cancer, Colorectal Cancer, Advanced Solid Tumor	125
Vanderbilt University/Ingram Cancer Center	Stage IV Colorectal Cancer AJCC v8, Head and Neck Squamous Cell Carcinoma, Malignant Solid Neoplasm	81
Sarah Cannon Research Institute	Advanced Solid Tumor, Prostate Cancer, Advanced Solid Tumors	63
Vanderbilt University	Autoimmune Diseases, Breast Cancer, Cardiac Failure	53
Tennessee Oncology	Multiple Myeloma, Breast Cancer, Carcinoma, Non-Small-Cell Lung	50
Vanderbilt-Ingram Cancer Center	Breast Cancer, Colorectal Cancer, Endometrial Cancer	36
The Children's Hospital at TriStar Centennial	Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia	26
Monroe Carell Jr. Children's Hospital at Vanderbilt	Acute Kidney Injury, Acute Myeloid Leukemia, Angelman Syndrome	13
Tennessee Oncology, PLLC	Advanced Solid Tumor, Breast Cancer, Advanced Breast Cancer	13
TriStar Centennial Medical Center	Coronary Artery Disease, Acute Lower Limb Arterial Occlusion, Acute Myeloid Leukemia (AML)	13
Vanderbilt Breast Center at One Hundred Oaks	Metastatic Malignant Solid Neoplasm, Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8	13
Sarah Cannon Research Institute Oncology Partners	Advanced Cancer, Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors	10
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN	Cardiovascular Disease, Acute Kidney Injury (AKI), Aging	10
Ascension Saint Thomas	Coronary Artery Disease, Mitral Regurgitation, Acute or Chronic Coronary Artery Disease	9
GSK Investigational Site	Neoplasms, Multiple Myeloma, Irritable Bowel Syndrome	9
Henry-Joyce Cancer Clinic	Colorectal Neoplasms, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma	8
Vanderbilt Eye Institute	Geographic Atrophy (GA), Macular Edema Secondary to Inflammation, Age - Related Macular Degeneration (AMD)	8
Meharry Medical College	ARDS, Cardiovascular Diseases, Cognitive Impairment, Mild	7
Tennessee Retina, PC	Neovascular Age-Related Macular Degeneration (nAMD), Age-related Macular Degeneration (AMD), Choroidal Melanoma	7
Vanderbilt Medical Center	Acinar Cell Carcinoma, Advanced Cancer, Alzheimer Disease	7
Autonomic Dysfunction Center/ Vanderbilt University Medical Center	Autonomic Failure, Multiple System Atrophy, Pure Autonomic Failure	6
Centennial Medical Center	Cardiovascular Diseases, Coronary Artery Disease, Heart Failure	6
Sarah Cannon Research Institute (SCRI) Oncology Partners	Advanced Solid Tumor, Metastatic Solid Tumor, Ovarian Cancer	6
Tennessee Oncology, PLLC - Investigational Drug Services	Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate, Hormone Sensitive Prostate Cancer	6

Active & Upcoming Studies in Nashville (2026)

Recruiting trials in Nashville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Common conditions studied in Nashville

Breast Cancer (40 active studies)
Colorectal Cancer (33 active studies)
Advanced Solid Tumor (30 active studies)
Ovarian Cancer (29 active studies)
Prostate Cancer (25 active studies)
Endometrial Cancer (23 active studies)

Leading research sponsors in Nashville

Vanderbilt University Medical Center
AstraZeneca
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Eli Lilly and Company

Frequently asked questions

How many paid clinical trials are currently recruiting in Nashville?

There are approximately 1,346 recruiting clinical trials in Nashville, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Nashville pay participants?

Most recruiting trials in Nashville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Nashville?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Nashville?

The most common conditions under active study in Nashville include Breast Cancer (40), Colorectal Cancer (33), Advanced Solid Tumor (30), Ovarian Cancer (29), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Nashville?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Nashville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Nashville?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Nashville?

Recruiting research sites in Nashville include Vanderbilt University Medical Center, SCRI Oncology Partners, Vanderbilt University/Ingram Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Nashville right now?

The largest active categories in Nashville are Cancer & tumors (553), Cardiovascular (91), Neurology & pain (63). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Related healthcare resources in Tennessee

Latest Nashville, TN clinical trials research report

Trials by condition in Nashville

Breast Cancer· 40 Colorectal Cancer· 33 Ovarian Cancer· 29 Prostate Cancer· 25 Endometrial Cancer· 23 Multiple Myeloma· 22

Conditions in Oncology (Nashville, TN)

Solid tumor· 105 Non-small cell lung cancer (NSCLC)· 68 Breast cancer· 47 Colorectal cancer· 41 Pancreatic cancer· 34 Ovarian cancer· 32 Head and neck cancer· 30 Cancer (any)· 30 Prostate cancer· 26 Endometrial cancer· 23 Multiple myeloma· 22 Metastatic breast cancer· 19 Gastric cancer· 18 Esophageal cancer· 18 Bladder cancer· 18 Acute myeloid leukemia (AML)· 17 Non-Hodgkin lymphoma· 16 Melanoma· 16 Metastatic prostate cancer· 15 Triple-negative breast cancer· 12 Cervical cancer· 12 Lung cancer· 11 Chronic lymphocytic leukemia (CLL)· 10 Myelodysplastic syndromes (MDS)· 10 Hematologic malignancy· 10 Small cell lung cancer· 9 Gastroesophageal junction cancer· 8 Leukemia (other)· 8 Small lymphocytic lymphoma· 8 Kidney cancer· 7 Metastatic colorectal cancer· 6 Colon cancer· 6 Biliary tract cancer· 6 HER2-negative breast cancer· 5 Fallopian tube cancer· 5 Diffuse large B-cell lymphoma (DLBCL)· 5 Follicular lymphoma· 5 Thyroid cancer· 5 Sarcoma· 5 Neuroblastoma· 5 Mesothelioma· 5 HER2-positive breast cancer· 4 Rectal cancer· 4 Glioma· 4 Myelofibrosis· 4 Mantle cell lymphoma· 4 Glioblastoma· 3 Brain cancer· 3 Chronic myelomonocytic leukemia· 3 Marginal zone lymphoma· 3 Osteosarcoma· 3 Ewing sarcoma· 3 Neuroendocrine tumors· 3 Liver cancer· 2 Uterine cancer· 2 Brain metastases· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Skin cancer· 2 Rhabdomyosarcoma· 2 Gastrointestinal cancer· 1 Burkitt lymphoma· 1

Oncology Clinical Trials in Nashville, TN

Newly added in Nashville

402 clinical trials for Oncology

Top Research Study Locations in Nashville

Active & Upcoming Studies in Nashville (2026)

Cancer & tumors (553 active studies)

Cardiovascular (91 active studies)

Neurology & pain (63 active studies)

Diabetes & metabolic (50 active studies)

Eye & vision (18 active studies)

Mental health & behavior (15 active studies)

HIV / STI (8 active studies)

Vaccines (7 active studies)

Pediatric (7 active studies)

Common conditions studied in Nashville

Leading research sponsors in Nashville

Frequently asked questions

How many paid clinical trials are currently recruiting in Nashville?

Do clinical trials in Nashville pay participants?

Who can participate in a clinical trial in Nashville?

What conditions are most commonly studied in Nashville?

Are there clinical trials for healthy volunteers in Nashville?

How do I enroll in a clinical trial in Nashville?

Where can I take part in paid clinical trials in Nashville?

What kinds of studies are recruiting in Nashville right now?

Browse more clinical trials

Other cities in Tennessee

Related healthcare resources in Tennessee

Trials by condition in Nashville

Conditions in Oncology (Nashville, TN)